Dhampur Bio Organics profit and loss

Latest FY26

Revenue: ₹3,133cr+16.4% on FY25
EBITDA: ₹131cr−2.9% on FY25
Net profit: ₹25.2cr+71.4% on FY25
EPS: ₹3.81+72.4% on FY25

₹ crore except per share

Tap a line for its trend	Last 12Mto Jun 2026	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023

Expenses
	3,268	3,133	2,693	2,394	2,654
	31.5	31.8	3.7	23.9	11.4
	3,300	3,165	2,697	2,418	2,666
	1,435	1,475	1,362	1,604	1,588
	103	41.3	31.6	31.0	3.9
	47.7	81.9	−8.7	−264	244
	112	113	101	96.7	108
	56.9	63.0	67.1	45.3	40.8
	57.4	58.8	53.9	49.5	40.5
	1,432	1,291	1,072	791	506
	3,244	3,124	2,679	2,353	2,531
	138	131	135	136	205
	81.0	72.1	80.9	87.0	164
Profit
	55.6	40.9	17.5	65.5	135
	0.0	0.0	−1.8	0.0	0.0
	55.6	40.9	15.7	65.5	135
	6.5	6.5	4.3	11.1	22.4
	15.6	9.3	−3.3	7.9	1.2
	22.1	15.7	1.0	19.0	23.7
	84.0	25.2	14.7	46.5	111
	33.4	25.2	14.7	46.5	111
	50.5	0.0	0.0	0.0	0.0
	2.7	2.7	2.0	−0.9	−1.1
	86.7	27.8	16.7	45.6	110
	84.0	25.2	16.7	46.5	111
Per share
	₹12.75	₹3.81	₹2.21	₹7.00	₹16.74
	₹12.68	₹3.80	₹2.21	₹7.00	₹16.74
Continuing & discontinued operations
	62.2	0.0	0.0	0.0	0.0
	11.6	0.0	0.0	0.0	0.0
Other comprehensive income — detail
	2.7	2.7	2.0	—	—
	—	0.1	1.8	−1.2	−2.4
	—	0.0	0.4	—	—
	—	—	—	−0.3	−0.6
	2.7	2.6	0.7	−0.0	1.0
	—	—	—	0.0	0.3
	86.7	27.8	—	45.6	110
Per share — as-filed variants
	₹5.07	₹3.81	₹2.21	₹7.00	₹16.74
	₹5.04	₹3.80	₹2.21	₹7.00	₹16.74
	₹7.68	₹0.00	₹0.00	₹0.00	₹0.00
	₹7.64	₹0.00	₹0.00	₹0.00	₹0.00
Derived — gross profit (revenue − materials − purchases − Δ inventories)
	1,683	1,535	1,308	1,024	818
	51.5%	49.0%	48.6%	42.8%	30.8%
Adjusted (ex-exceptional items) — derived
	55.6	40.9	17.5	65.5	135
	0.0	0.0	−1.8	0.0	0.0
	84.0	25.2	16.3	46.5	111
	₹12.75	₹3.81	₹2.46	₹7.00	₹16.74

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

DBOL₹124.00

Dhampur Bio Organics Limited

· FMCG & Retail

Annual Quarterly₹ CrorePeersMAGADSUGAR ZUARIIND DWARKESH DHAMPURSUG UGARSUGAR UTTAMSUGAR MAWANASUG DCMSRINDMcap ₹823 Cr

View

In ₹ Crore except Per Share 12 Months Ending	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
Revenue from Operations	2,654.4	2,394.4	2,693.0	3,133.4	3,268.3
Other Income	11.4	23.9	3.7	31.8	31.5
Total Income	2,665.9	2,418.3	2,696.6	3,165.2	3,299.8
Expenses
+ Cost of Materials Consumed	1,588.3	1,604.1	1,362.2	1,475.2	1,434.6
+ Purchases of Stock-in-Trade	3.9	31.0	31.6	41.3	102.8
+ Changes in Inventories	244.0	-264.5	-8.7	81.9	47.7
+ Employee Benefit Expense	108.0	96.7	100.6	113.4	112.3
+ Finance Costs	40.8	45.3	67.1	63.0	56.9
+ Depreciation & Amortisation	40.5	49.5	53.9	58.8	57.4
+ Other Expenses	505.6	790.7	1,072.4	1,290.8	1,432.5
Total Expenses	2,531.1	2,352.8	2,679.2	3,124.3	3,244.2
EBITDA	204.7	136.4	134.8	130.9	138.4
EBIT	164.2	87.0	80.9	72.1	81.0
Profit
PBT before Exceptional Items	134.8	65.5	17.5	40.9	55.6
+ Exceptional Items	0.0	0.0	-1.8	0.0	0.0
Pretax Income	134.8	65.5	15.7	40.9	55.6
+ Current Tax	22.4	11.1	4.3	6.5	6.5
+ Deferred Tax	1.2	7.9	-3.3	9.3	15.6
Tax Expense	23.7	19.0	1.0	15.7	22.1
Net Income	111.1	46.5	14.7	25.2	84.0
+ Net Income — Continuing Ops	111.1	46.5	14.7	25.2	33.4
+ Net Income — Discontinued Ops	0.0	0.0	0.0	0.0	50.5
+ Other Comprehensive Income	-1.1	-0.9	2.0	2.7	2.7
Total Comprehensive Income	110.0	45.6	16.7	27.8	86.7
Net Income to Common	111.1	46.5	16.7	25.2	84.0
Per Share
Basic EPS	16.74	7.00	2.21	3.81	12.75
Diluted EPS	16.74	7.00	2.21	3.80	12.68
Continuing & Discontinued Operations
+ Discontinued Operations — before Tax	0.0	0.0	0.0	0.0	62.2
+ Tax — Discontinued Operations	0.0	0.0	0.0	0.0	11.6
Other Comprehensive Income — detail
+ Other Comprehensive Income	—	—	2.0	2.7	2.7
+ Items NOT to be Reclassified to P&L	-2.4	-1.2	1.8	0.1	—
+ Tax on Items NOT to be Reclassified	—	—	0.4	0.0	—
+ Tax on Items NOT to be Reclassified — alt tag	-0.6	-0.3	—	—	—
+ Items to be Reclassified to P&L	1.0	-0.0	0.7	2.6	2.7
+ Tax on Items to be Reclassified — alt tag	0.3	0.0	—	—	—
Comprehensive Income — Owners of Parent	110.0	45.6	—	27.8	86.7
Per Share — as-filed variants
Basic EPS — Continuing Operations	16.74	7.00	2.21	3.81	5.07
Diluted EPS — Continuing Operations	16.74	7.00	2.21	3.80	5.04
Basic EPS — Discontinued Operations	0.00	0.00	0.00	0.00	7.68
Diluted EPS — Discontinued Operations	0.00	0.00	0.00	0.00	7.64
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit	818.3	1,023.8	1,307.9	1,535.1	1,683.2
Gross Margin %	30.83	42.76	48.57	48.99	51.50
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)	134.8	65.5	17.5	40.9	55.6
− Exceptional Items (reconciliation)	0.0	0.0	-1.8	0.0	0.0
Net Income Adj (tax-effected)	111.1	46.5	16.3	25.2	84.0
EPS Adj	16.74	7.00	2.46	3.81	12.75
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value	10.00	10.00	10.00	10.00	10.00
Paid Up Equity Capital	66.4	66.4	6.6	66.4	66.4

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.